Insider Trading Alert - ADS, OMCL And CRUS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 17, 2014, 81 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $68.97 to $30,520,350.00.

Highlighted Stocks Traded by Insiders:

Alliance Data Systems (ADS) - FREE Research Report

Anderson Bruce K, who is Director at Alliance Data Systems, sold 886 shares at $281.54 on Dec. 17, 2014. Following this transaction, the Director owned 854,694 shares meaning that the stake was reduced by 0.1% with the 886-share transaction.

The shares most recently traded at $282.88, up $1.34, or 0.48% since the insider transaction. Historical insider transactions for Alliance Data Systems go as follows:

  • 4-Week # shares sold: 1,250
  • 12-Week # shares sold: 1,250
  • 24-Week # shares sold: 1,250

The average volume for Alliance Data Systems has been 607,300 shares per day over the past 30 days. Alliance Data Systems has a market cap of $16.8 billion and is part of the services sector and diversified services industry. Shares are up 5.95% year-to-date as of the close of trading on Tuesday.

Alliance Data Systems Corporation provides marketing and loyalty solutions in the United States, Canada, and other countries. The company has a P/E ratio of 32.2. Currently, there are 9 analysts who rate Alliance Data Systems a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ADS - FREE

TheStreet Quant Ratings rates Alliance Data Systems as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Alliance Data Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Omnicell (OMCL) - FREE Research Report

Petersmeyer Gary S, who is Director at Omnicell, sold 670 shares at $33.25 on Dec. 17, 2014. Following this transaction, the Director owned 19,035 shares meaning that the stake was reduced by 3.4% with the 670-share transaction.

The shares most recently traded at $32.18, down $1.07, or 3.33% since the insider transaction. Historical insider transactions for Omnicell go as follows:

  • 4-Week # shares sold: 670
  • 12-Week # shares sold: 1,139
  • 24-Week # shares sold: 23,785

The average volume for Omnicell has been 190,600 shares per day over the past 30 days. Omnicell has a market cap of $1.2 billion and is part of the technology sector and computer software & services industry. Shares are up 27.81% year-to-date as of the close of trading on Tuesday.

Omnicell, Inc. provides automation solutions for medication and supply management in healthcare worldwide. The company operates in two segments, Acute Care and Non-Acute Care. The company has a P/E ratio of 42.7. Currently, there are 3 analysts who rate Omnicell a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on OMCL - FREE

TheStreet Quant Ratings rates Omnicell as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Omnicell Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cirrus Logic (CRUS) - FREE Research Report

Thomas Scott, who is VP General Counsel at Cirrus Logic, sold 11,624 shares at $22.00 on Dec. 17, 2014. Following this transaction, the VP General Counsel owned 23,064 shares meaning that the stake was reduced by 33.51% with the 11,624-share transaction.

The shares most recently traded at $22.39, up $0.39, or 1.74% since the insider transaction. Historical insider transactions for Cirrus Logic go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 10,897
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 10,897
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 16,208

The average volume for Cirrus Logic has been 1.5 million shares per day over the past 30 days. Cirrus Logic has a market cap of $1.5 billion and is part of the technology sector and electronics industry. Shares are up 12.07% year-to-date as of the close of trading on Tuesday.

Cirrus Logic, Inc., a fabless semiconductor company, develops analog and mixed-signal integrated circuits (ICs) for a range of consumer and industrial markets. The company has a P/E ratio of 23.0. Currently, there are 2 analysts who rate Cirrus Logic a buy, 2 analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRUS - FREE

TheStreet Quant Ratings rates Cirrus Logic as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Cirrus Logic Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Global Stocks Mixed as Oil, Commodity Price Surges Ignite Fresh Inflation Talk

Global Stocks Mixed as Oil, Commodity Price Surges Ignite Fresh Inflation Talk

P&G Buys Consumer Healthcare Unit From Germany's Merck in First Peltz-Era Deal

P&G Buys Consumer Healthcare Unit From Germany's Merck in First Peltz-Era Deal

Amazon's Stock Spikes After Jeff Bezos Says He Has 100 Million Prime Members

Amazon's Stock Spikes After Jeff Bezos Says He Has 100 Million Prime Members

Oil Prices Soaring to $100 Makes These 4 Stocks Winners

Oil Prices Soaring to $100 Makes These 4 Stocks Winners

Amazon, Procter & Gamble, Southwest and Netflix - 5 Things You Must Know

Amazon, Procter & Gamble, Southwest and Netflix - 5 Things You Must Know